Close
ACHEMA MIDDLE EAST 2026

IDEAYA Biosciences meets clinical protocol criteria for cohort expansion in skin melanoma for phase 2 GNAQ/11 basket trial

IDEAYA Biosciences Inc, an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced that it has met the clinical...

GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine

GSK and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago’s recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK’s pandemic...

iBio Says IBM Watson Health Selects Co To Receive 18 Months Of Use Of IBM Clinical Development Solution

IBM Watson Health selected iBio to receive 18 months use of the IBM clinical development (ICD) solution at no cost. IBM Watson Health recently began...

Thermo Fisher Scientific and First Genetics JCS Partner to Develop Next-Generation Sequencing-Based Diagnostics in Russia

Thermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice,...

Antares Vision acquires pharma packaging leak specialist for $17.9m

Antares Vision has acquired Convel for €15.7m ($17.9m). The Italian company specialises in automated inspection in the pharmaceutical industry; operating in Italy and boasts...

My Personal Therapeutics and Pentavere receive EUREKA AI Therapeutics Funding to support the development of My Personal Therapeutics – digital therapeutics for Lung Cancer

This funding represents the international support for R&D, particularly to promote the acceleration and utilisation of artificial intelligence in clinical decision making. My Personal Therapeutics,...

Cergentis appoints new CEO and Board members

Cergentis, a genomics company that develops and commercializes kits and services based on its proprietary Targeted Locus Amplification (TLA) technology, announced the appointment of...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...